QCI Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-240
Closed -$7K 354
2020
Q1
$7K Hold
240
﹤0.01% 438
2019
Q4
$7K Hold
240
﹤0.01% 472
2019
Q3
$6K Sell
240
-344
-59% -$8.7K ﹤0.01% 472
2019
Q2
$15K Buy
584
+344
+143% +$8.5K ﹤0.01% 407
2019
Q1
$6K Hold
240
﹤0.01% 492
2018
Q4
$6K Hold
240
﹤0.01% 484
2018
Q3
$6K Hold
240
﹤0.01% 492
2018
Q2
$6K Hold
240
﹤0.01% 466
2018
Q1
$6K Hold
240
﹤0.01% 493
2017
Q4
$6K Hold
240
﹤0.01% 502
2017
Q3
$6K Hold
240
﹤0.01% 449
2017
Q2
$5K Hold
240
﹤0.01% 522
2017
Q1
$4K Hold
240
﹤0.01% 476
2016
Q4
$4K Hold
240
﹤0.01% 444
2016
Q3
$5K Hold
240
﹤0.01% 428
2016
Q2
$6K Hold
240
﹤0.01% 429
2016
Q1
$7K Hold
240
﹤0.01% 402
2015
Q4
$7K Hold
240
﹤0.01% 395
2015
Q3
$7K Hold
240
﹤0.01% 386
2015
Q2
$7K Hold
240
﹤0.01% 376
2015
Q1
$6K Hold
240
﹤0.01% 393
2014
Q4
$5K Hold
240
﹤0.01% 430
2014
Q3
$6K Hold
240
﹤0.01% 423
2014
Q2
$6K Hold
240
﹤0.01% 404
2014
Q1
$5K Hold
240
﹤0.01% 413
2013
Q4
$4K Hold
240
﹤0.01% 438
2013
Q3
$4K Hold
240
﹤0.01% 417
2013
Q2
$4K Buy
+240
New +$4K ﹤0.01% 408

Other funds holding NVO

QCI Asset Management's NVO Position: Q2 2020 in Review

QCI Asset Management sold out of Novo Nordisk (NVO) in Q2 2020, closing a stake of 240 shares — an estimated $7K sold.

QCI Asset Management first reported a position in NVO in Q2 2013 and held it in 28 quarters. The position peaked at $15K in Q2 2019. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • QCI Asset Management reported no remaining Novo Nordisk position as of Q2 2020 after selling out during the quarter.
  • QCI Asset Management sold 240 Novo Nordisk shares in Q2 2020, an estimated $7K.
  • QCI Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 28 quarters.
  • QCI Asset Management's Novo Nordisk position peaked at $15K in Q2 2019.
  • 661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.